#China #Jinan #Angelalign Technology #Premolar Extraction #Legal Appeal

Angelalign Technology Inc. to Appeal Chinese Court Decision

In a bold move, Angelalign Technology Inc. (6699.HK) has declared that it will appeal a recent ruling made by the Jinan Intermediate People's Court in China concerning its premolar extraction systems. The ruling, delivered on August 10, 2026, requires Angel's subsidiaries in China to cease using certain systems that form the basis of their innovative dental solutions. Importantly, this decision affects only their operations in China and does not extend to their global clientele.

The Context of the Case

This preliminary court ruling emerged amidst an ongoing patent dispute between Angelalign and Align Technology Inc. (ALGN), the latter being the plaintiff in the case. Align claims that Angel's A7 Premolar Extraction Solution infringes on its patent rights, a contention that Angelalign firmly denies. The company has won multiple patent disputes internationally and continues to advocate for fair competition in the orthodontic market.

Fox Hu, CEO of Angelalign, emphasized the localized nature of the ruling, stating, "The court’s decision applies only within China. Importantly, it does not directly affect our customers or patients. We remain confident that our A7 Premolar Extraction Solution is not in violation of any existing patents."

Confidence in Judicial Process

Despite the judgment, Angelalign maintains a positive outlook regarding the outcome of their upcoming appeal. The firm has previously triumphed in similar legal battles, including a decisive ruling from the Düsseldorf Unified Patent Court which rejected a preliminary injunction against the A7 Solution. This ruling, which was finalized on May 12, 2026, reinforced Angelalign’s belief in the non-infringement of their product.

The Jinan court's preliminary injunction, should it not be overturned, would only come into effect following the conclusion of the appeal process. Until then, Angelalign continues normal operations in other markets without interruption.

A Solid Foundation in Innovation

Founded in 2003, Angelalign has significantly impacted the dental and orthodontic landscapes, providing cutting-edge solutions for complex orthodontic cases. Celebrating over two million successful treatments globally, Angelalign’s portfolio includes a range of innovative products, such as the A6 Mandibular Advancement and the AngelButton™, which have garnered support from top orthodontists worldwide. Their commitment to technological advancement is evident in their strategic global expansion, which initiated in 2023 and currently spans over 60 countries.

The company’s robust financial health, with a market capitalization of $2 billion, coupled with its unwavering commitment to intellectual property and innovation, positions Angelalign as a trusted partner for orthodontists aiming for exceptional clinical outcomes.

Looking Ahead

As this legal saga unfolds, Angelalign Technology Inc. remains dedicated to serving their clients with integrity and innovation. The outcome of the appeal is anticipated to have significant implications for the company’s operations in China and its overall competitive landscape. Further updates on this matter will be available on their official website. For those interested in detailed legal proceedings, more information may be found at Angelalign Legal Proceedings.